IRVINE, Calif., Feb. 8, 2022 /PRNewswire/ — Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the FDA approval of Juvéderm® Volbella® XC for improvement of infraorbital hollows in adults over the age of 21.2 According to…Original Article
You may also like
Dupixent (dupilumab) Approved in the U.S. as the First...
U.S. Food and Drug Administration Updates Camzyos...
FDA Grants Isturisa (osilodrostat) Expanded Indication...
Neurelis Announces FDA Approval for Immediate Use...
Mirum’s Livmarli Now FDA Approved in Tablet...
FDA Grants Interchangeable Designation to Yuflyma...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.